Syschem (India) Limited (SYSCHEM.BO)
INR 48.01
(-1.84%)
INR 48.01
(-1.84%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.07 Billion INR | 52.07% |
| 2022 | 704.08 Million INR | 33.18% |
| 2021 | 528.66 Million INR | -24.53% |
| 2020 | 700.45 Million INR | 33.57% |
| 2019 | 524.41 Million INR | 5.08% |
| 2018 | 499.07 Million INR | 2.72% |
| 2017 | 485.84 Million INR | 31.76% |
| 2016 | 368.72 Million INR | -4.06% |
| 2015 | 384.33 Million INR | -3.41% |
| 2014 | 397.89 Million INR | 0.04% |
| 2013 | 397.72 Million INR | 19.6% |
| 2012 | 332.55 Million INR | 86.49% |
| 2011 | 178.32 Million INR | 170.94% |
| 2010 | 65.81 Million INR | 42.85% |
| 2009 | 46.07 Million INR | -53.88% |
| 2008 | 99.89 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -569.56 Million INR | -153.19% |
| 2023 Q2 | 590.73 Million INR | 0.0% |
| 2023 FY | 1.07 Billion INR | 52.07% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.07 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 458.57 Million INR | 0.0% |
| 2022 Q4 | 704.08 Million INR | 0.0% |
| 2022 FY | 704.08 Million INR | 33.18% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 528.66 Million INR | 0.0% |
| 2021 Q2 | 699.15 Million INR | 0.0% |
| 2021 FY | 528.66 Million INR | -24.53% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 585 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 700.45 Million INR | 0.0% |
| 2020 FY | 700.45 Million INR | 33.57% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 524.41 Million INR | 0.0% |
| 2019 FY | 524.41 Million INR | 5.08% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 476.63 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 494.56 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 499.07 Million INR | 2.72% |
| 2018 Q4 | 499.07 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 449.6 Million INR | 0.0% |
| 2017 Q4 | 485.84 Million INR | 0.0% |
| 2017 FY | 485.84 Million INR | 31.76% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q2 | 431.88 Million INR | 0.0% |
| 2016 FY | 368.72 Million INR | -4.06% |
| 2016 Q4 | 368.72 Million INR | 0.0% |
| 2015 Q2 | 409.29 Million INR | 0.0% |
| 2015 Q4 | 384.33 Million INR | 0.0% |
| 2015 FY | 384.33 Million INR | -3.41% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 402.91 Million INR | 0.0% |
| 2014 Q4 | 397.89 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 397.89 Million INR | 0.04% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 397.72 Million INR | 19.6% |
| 2013 Q2 | 401.32 Million INR | 0.0% |
| 2013 Q4 | 397.72 Million INR | 0.0% |
| 2012 Q4 | 332.55 Million INR | 0.0% |
| 2012 FY | 332.55 Million INR | 86.49% |
| 2011 FY | 178.32 Million INR | 170.94% |
| 2011 Q4 | 178.32 Million INR | 0.0% |
| 2010 FY | 65.81 Million INR | 42.85% |
| 2009 FY | 46.07 Million INR | -53.88% |
| 2008 FY | 99.89 Million INR | 0.0% |
| 2008 Q4 | 99.89 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -4066.041% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -7.463% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -5001.081% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -1895.856% |
| Sunil Healthcare Limited | 902.83 Million INR | -18.596% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -50215.648% |
| MedPlus Health Services Limited | 14.27 Billion INR | 92.499% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -6.61% |
| Patidar Buildcon Limited | 25.57 Million INR | -4087.068% |
| Roopa Industries Limited | 493.08 Million INR | -117.146% |
| Smruthi Organics Limited | 485.72 Million INR | -120.439% |
| Trident Lifeline Limited | 331.26 Million INR | -223.224% |
| PANJON LTD. | 25.38 Million INR | -4118.244% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -413.679% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -562.269% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -7048.121% |
| Anuh Pharma Limited | 1.54 Billion INR | 30.681% |
| Crestchem Limited | 23.94 Million INR | -4371.195% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -7887.445% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -805.676% |
| Tyche Industries Limited | 101.64 Million INR | -953.43% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 42.474% |
| Trimurthi Limited | 101.36 Thousand INR | -1056250.631% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -430.126% |
| Norris Medicines Limited | 278.17 Million INR | -284.91% |
| Zenlabs Ethica Limited | 301.35 Million INR | -255.302% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -267.343% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 35.561% |
| Parmax Pharma Limited | 117.56 Million INR | -810.724% |
| Veerhealth Care Limited | 62.78 Million INR | -1605.507% |
| Deccan Health Care Limited | 111.33 Million INR | -861.699% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 37.538% |
| Makers Laboratories Limited | 569.18 Million INR | -88.116% |
| Lactose (India) Limited | 536.39 Million INR | -99.613% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -28.515% |
| Zenith Healthcare Limited | 24.03 Million INR | -4354.824% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -590.496% |
| Bacil Pharma Limited | 1.12 Million INR | -94737.644% |
| PRAVEG LIMITED | 767.53 Million INR | -39.501% |
| Denis Chem Lab Limited | 289.82 Million INR | -269.44% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 37.613% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -431.131% |
| Colinz Laboratories Limited | 24.1 Million INR | -4341.888% |
| Godavari Drugs Limited | 957.86 Million INR | -11.782% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -357999.331% |
| Zenotech Laboratories Limited | 156.64 Million INR | -583.518% |
| Panchsheel Organics Limited | 340.2 Million INR | -214.73% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -119.244% |
| Vivanza Biosciences Limited | 148.63 Million INR | -620.386% |
| Phaarmasia Limited | 211.49 Million INR | -406.261% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 28.647% |
| Medi-Caps Limited | 63.01 Million INR | -1599.119% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -809.507% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -442.484% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 5.322% |
| Mercury Laboratories Limited | 171.18 Million INR | -525.459% |
| Gennex Laboratories Limited | 535.21 Million INR | -100.055% |
| BDH Industries Limited | 312.53 Million INR | -242.591% |
| Coral Laboratories Limited | 281.83 Million INR | -279.904% |
| Concord Drugs Limited | 249.88 Million INR | -328.482% |
| Bharat Parenterals Limited | 2.65 Billion INR | 59.694% |
| Beryl Drugs Limited | 85.63 Million INR | -1150.312% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -511.255% |
| Evoq Remedies Limited | 116.23 Million INR | -821.19% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -572.544% |
| Transchem Limited | 6.72 Million INR | -15833.289% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -11968.496% |
| Parnax Lab Limited | 1.17 Billion INR | 8.541% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -2451.027% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -1.236% |
| Cian Healthcare Limited | 1.03 Billion INR | -3.516% |
| Trinity League India Limited | 876 Thousand INR | -122127.968% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 47.592% |
| Natural Capsules Limited | 1.47 Billion INR | 27.518% |
| Auro Laboratories Limited | 433.09 Million INR | -147.223% |